Category Archives: Hormone Replacement Therapy

BioTe - Bio Identical Hormone Replacement Therapy - With Pellets ! A brief rundown of the utilization of BHRT with pellets - through the leading company in the nation: BioTE. By: Frederick Brown … Continue reading →

Dr James Granger on Bio-Identical Hormone Replacement Therapy in Marietta, Atlanta, GA Dr Granger talks about Bio-Identical Hormone replacement Therapy vs the pharmaceutical version and why it is so important to understand the difference. He al... By: Eric LeRiche … Continue reading →

Natpara (rhPTH [1-84]) is the most interesting candidate in NPS Pharmas (NPSP) pipeline. The candidate has been developed for the treatment of hypoparathyroidism. Hypoparathyroidism refers to a rare endocrine disorder which results in the human body producing inadequate levels of parathyroid hormone. NPS Pharma made a significant move in its attempt to bring Natpara, a replacement therapy, to the market by submitting a Biologic License Application (:BLA) to the U.S. Food and Drug Administration (:FDA). Approval of Natpara by the FDA for the hypoparathyroidism would be highly welcomed by hypoparathyroidism patients since the disease currently does not nave any FDA approved replacement therapy. Patients suffering from the disorder are currently treated with large doses of calcium supplementation and active vitamin D therapy. This helps to raise the levels of calcium in the blood while bringing down the severity of symptoms. However, this type of therapy has attendant risks like calcifications in the kidneys, arteries or brain. Apart from Natpara, NPS Pharmas pipeline includes early-stage candidates like NPSP795. The candidate, a calcilytic compound, is being developed to treat rare deficiencies involving increased calcium receptor activity. Gattex is NPS Pharmas sole marketed product. NPS Pharma launched Gattex in the U.S. in Feb … Continue reading →

SGTV Ask The Expert Ronald Cheek Hormone Replacement Therapy By: DMC Sinai-Grace Hospital Health Videos … Continue reading →

San Jose, CA (PRWEB) October 22, 2013 Follow us on LinkedIn - The market for Testosterone Replacement Therapy (TRT) has been witnessing healthy growth over the last decade. The introduction of topical gel formulations at the turn of the century has been a significant milestone in the evolution of the TRT market. In subsequent years, manufacturers launched several gel based products with varying efficacy levels. Being a condition usually associated with aging, the aging world population is benefiting the TRT market. Although prevalence rates remain high, a very small share of the addressable market is presently being served. This presents tremendous untapped potential for further growth in the market, as awareness and product choices improve. Although prospects for topical gels and solutions appear bright, injectables have been witnessing a rise in adoption over the recent years. With new injectables and oral formulations in pipeline, the TRT market is likely to witness a trend towards more convenient and efficacious therapies. Awareness and diagnosis remain critical to the future of the market. Given the stigma attached to hormone therapy, significant marketing activity is required to raise awareness and improve sales of TRT products. Aggressive marketing campaigns by pharmaceutical companies as well as … Continue reading →

by Cornelius Swart, KGW.com Staff kgw.com Posted on October 22, 2013 at 5:07 PM Updated today at 5:59 AM PORTLAND-- The US Supreme Court ruled Monday that a case between a West Linn woman and Danish pharmaceutical company Novo Nordisk A/S will have to go trial. Suzanne Lukas-Werner claimed she got breast cancer in 2009 after using the Novo Nordisk hormone replacement therapy drug known as Activella for six years. She said she underwent a mastectomy of her right breast and three lymph nodes were removed. She went through several treatments of radiation and chemotherapy. Lukas-Werner filed a claim against Novo Nordisk and her Lake Oswego doctor in September 2010. She made a public statement to the press on Tuesday. "We've been kind of under attack with Novo Nordisk, said Lukas-Werner. We're the David versus the Goliath and Im surprised we've gotten this far. I was very surprised by the supreme court verdict. I'm very grateful." According to Law360, Novo Nordisk had tried to assert that an Oregon court had no jurisdiction over the drugmaker. Tuesday's ruling means the company will have to open its records to Lukas-Werner's attorneys and that the case is clear to go before a Multnomah … Continue reading →

Hormone Replacement Therapy for Women: Medical Minute with Dr. Richard Honaker In this Medical Minute watch Family Physician Dr. Richard Honaker talk when to use Hormone Replacement Therapy for women. By: BestDocsNetwork … Continue reading →

Testosterone Therapy for Men and Women Learn the role of testosterone in men and women by watching this discussion between AAG Health medical directors. In this video, you'll also find out the why... By: AAGHealthVideo … Continue reading →

Back in the 1990s, we invited every woman of menopause age to take hormone replacement therapy (HRT), as it gave promise of a longer, sweeter life. We thought there would be fewer heart attacks (we were wrong), fewer blood clots (wrong again) and fewer strokes (strike three, were out). The monumental Heart and Estrogen/Progestin Replacement Study (HERS) showed that when we thought we were helping we were actually hurting. This resulted in a dramatic drop in the use of estrogen-containing products. But now the question is how to help a woman who has intolerable menopause symptoms. A so-called natural cure using the herb black cohosh has been a bust well-controlled scientific studies have not shown its worthwhile, even though the supplement producers disagree. Anti-depressants offer some relief, but its minimal. When I was a medical student, believe it or not, valium was considered to be a viable treatment. The dose I was taught was 10 milligrams of valium four times daily thats enough to keep a race horse from complaining. The fact of the matter is HRT still has its place. For some women it might be used for just a few months and for others a couple of years. … Continue reading →

By Paula Spencer Scott WebMD Feature Treatments for menopause symptoms have come and gone. Once, hormone therapy was the second most prescribed drug in the U.S. Then in 2002, a major study found problems and doctors backed off prescribing it. Now you hear a lot about both hormonal and nonhormonal treatments for menopause, including bioidentical hormones. What's right for you? Hormone therapy involves taking estrogen plus, in most cases progestin. Progestin helps lower the risk of getting endometrial cancer from taking estrogen. Women without a uterus usually get just estrogen. Too Young for Menopause When she was 26, Lara Dietz learned she had breast cancer -- a shock to this mother of two very young children. Then came the second blow. When treatment began, so did premature menopause. "I was having hot flashes," she says. "I felt like I was 55 years old." When menopause occurs between ages 45 to 55, it is considered "natural." When it occurs before age 40 -- regardless the cause -- it is called premature menopause. The ovaries no longer produce an egg each month, so monthly menstrual cycles... Read the Too Young for Menopause article > > Hormones are given in different ways and … Continue reading →